Glenview Trust’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.1M | Sell |
25,137
-9,650
| -28% | -$6.19M | 0.22% | 89 |
|
|
2025
Q4 | $23.5M | Sell |
34,787
-5,942
| -15% | -$4.05M | 0.36% | 57 |
|
|
2025
Q3 | $26M | Buy |
40,729
+2,312
| +6% | +$1.4M | 0.41% | 56 |
|
|
2025
Q2 | $20.6M | Buy |
38,417
+3,844
| +11% | +$1.84M | 0.36% | 63 |
|
|
2025
Q1 | $14.5M | Buy |
34,573
+17,761
| +106% | +$7.71M | 0.28% | 89 |
|
|
2024
Q4 | $6.95M | Buy |
16,812
+10,162
| +153% | +$4.46M | 0.13% | 116 |
|
|
2024
Q3 | $3.36M | Sell |
6,650
-13
| -0.2% | -$6.32K | 0.06% | 165 |
|
|
2024
Q2 | $3.25M | Sell |
6,663
-90
| -1% | -$45.2K | 0.07% | 162 |
|
|
2024
Q1 | $3.65M | Sell |
6,753
-34
| -0.5% | -$18.6K | 0.08% | 155 |
|
|
2023
Q4 | $3.77M | Sell |
6,787
-278
| -4% | -$131K | 0.09% | 146 |
|
|
2023
Q3 | $3.09M | Sell |
7,065
-1,301
| -16% | -$649K | 0.09% | 144 |
|
|
2023
Q2 | $4.2M | Sell |
8,366
-68
| -0.8% | -$32.6K | 0.11% | 128 |
|
|
2023
Q1 | $4.22M | Hold |
8,434
| – | – | 0.13% | 122 |
|
|
2022
Q4 | $3.44M | Buy |
8,434
+58
| +0.7% | +$22.5K | 0.11% | 130 |
|
|
2022
Q3 | $2.73M | Sell |
8,376
-2,767
| -25% | -$1.02M | 0.1% | 132 |
|
|
2022
Q2 | $3.91M | Buy |
11,143
+5
| +0% | +$2.04K | 0.14% | 113 |
|
|
2022
Q1 | $6.09M | Sell |
11,138
-930
| -8% | -$489K | 0.2% | 97 |
|
|
2021
Q4 | $7.95M | Buy |
12,068
+1,800
| +18% | +$1.13M | 0.26% | 88 |
|
|
2021
Q3 | $6.39M | Sell |
10,268
-25
| -0.2% | -$16.8K | 0.25% | 92 |
|
|
2021
Q2 | $6.5M | Hold |
10,293
| – | – | 0.25% | 94 |
|
|
2021
Q1 | $5.04M | Sell |
10,293
-109
| -1% | -$54.6K | 0.22% | 96 |
|
|
2020
Q4 | $5.2M | Hold |
10,402
| – | – | 0.24% | 90 |
|
|
2020
Q3 | $4.09M | Hold |
10,402
| – | – | 0.21% | 96 |
|
|
2020
Q2 | $3.43M | Sell |
10,402
-2,268
| -18% | -$657K | 0.2% | 99 |
|
|
2020
Q1 | $3.07M | Hold |
12,670
| – | – | 0.21% | 99 |
|
|
2019
Q4 | $3.31M | Sell |
12,670
-150
| -1% | -$39.5K | 0.19% | 102 |
|
|
2019
Q3 | $3.49M | Hold |
12,820
| – | – | 0.21% | 101 |
|
|
2019
Q2 | $3.53M | Hold |
12,820
| – | – | 0.22% | 104 |
|
|
2019
Q1 | $2.87M | Hold |
12,820
| – | – | 0.18% | 114 |
|
|
2018
Q4 | $2.38M | Hold |
12,820
| – | – | 0.18% | 117 |
|
|
2018
Q3 | $3.2M | Hold |
12,820
| – | – | 0.2% | 113 |
|
|
2018
Q2 | $2.79M | Sell |
12,820
-932
| -7% | -$192K | 0.21% | 108 |
|
|
2018
Q1 | $2.63M | Sell |
13,752
-1,152
| -8% | -$213K | 0.18% | 115 |
|
|
2017
Q4 | $2.33M | Hold |
14,904
| – | – | 0.16% | 117 |
|
|
2017
Q3 | $2.32M | Hold |
14,904
| – | – | 0.17% | 115 |
|
|
2017
Q2 | $2.41M | Hold |
14,904
| – | – | 0.19% | 111 |
|
|
2017
Q1 | $2.3M | Buy |
14,904
+3,596
| +32% | +$496K | 0.18% | 111 |
|
|
2016
Q4 | $1.33M | Buy |
+11,308
| New | +$1.29M | 0.11% | 132 |
|
Other funds holding IDXX
VCM
VPM
Glenview Trust's IDXX Position: Q1 2026 in Review
Glenview Trust reduced its Idexx Laboratories (IDXX) stake by 28% in Q1 2026, selling an estimated $6.19M and leaving 25,137 shares worth $14.1M. The position accounts for 0.22% of the portfolio, ranked #89.
Glenview Trust first reported a position in IDXX in Q4 2016 and has held it in 38 quarters since. The position peaked at $26M in Q3 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Glenview Trust held 25,137 shares of Idexx Laboratories worth $14.1M as of Q1 2026.
- Glenview Trust sold 9,650 Idexx Laboratories shares in Q1 2026, an estimated $6.19M.
- Idexx Laboratories made up 0.22% of Glenview Trust's portfolio in Q1 2026, its #89 holding.
- Glenview Trust first reported a position in Idexx Laboratories in Q4 2016 and has held it in 38 quarters since.
- Glenview Trust's Idexx Laboratories position peaked at $26M in Q3 2025.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Glenview Trust's 13F filing for Q1 2026, filed 8 May 2026.